Delek Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$18.3M Sell
112,159
-19,865
-15% -$2.75M 0.71% 57
2019
Q1
$19.2M Buy
+132,024
New +$19.1M 0.8% 47
2018
Q4
Sell
-100,746
Closed -$19.1M 257
2018
Q3
$19.1M Sell
100,746
-30,000
-23% -$5.51M 0.8% 33
2018
Q2
$21.8M Buy
130,746
+19,414
+17% +$3.12M 0.94% 23
2018
Q1
$18.8M Sell
111,332
-1,340
-1% -$225K 0.96% 22
2017
Q4
$18.4M Buy
+112,672
New +$20.2M 0.99% 23

Other funds holding AGN

Delek Group's AGN Position: Q2 2019 in Review

Delek Group reduced its Allergan plc (AGN) stake by 15% in Q2 2019, selling an estimated $2.75M and leaving 112,159 shares worth $18.3M. The position accounts for 0.71% of the portfolio, ranked #57.

Delek Group first reported a position in AGN in Q4 2017 and has held it in 6 quarters since. The position peaked at $21.8M in Q2 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Delek Group held 112,159 shares of Allergan plc worth $18.3M as of Q2 2019.
  • Delek Group sold 19,865 Allergan plc shares in Q2 2019, an estimated $2.75M.
  • Allergan plc made up 0.71% of Delek Group's portfolio in Q2 2019, its #57 holding.
  • Delek Group first reported a position in Allergan plc in Q4 2017 and has held it in 6 quarters since.
  • Delek Group's Allergan plc position peaked at $21.8M in Q2 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.